Close Menu

NEW YORK (GenomeWeb News) – Kaiser Permanente and the University of California, San Francisco, have won a $24.8 million grant from the National Institutes of Health to use information and biospecimens from 100,000 of Kaiser Permanente's members in a large-scale study of how genetic and environmental interactions affect human health.

The Kaiser Permanente Research Program on Genes, Environment, and Health (RPGEH) and UCSF will use the two-year stimulus grant from NIH to conduct genome-wide analysis of DNA samples from 100,000 Kaiser volunteers in Northern California.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.